| | Biotechnology Research in an Age of Terrorism: Confronting |
| | 1,49 | | MB | the Dual Use Dilemma |
| | 122 | | stron |
| | 5726 | | ID | National Research Council |
| | 2003 | | rok |
| | Contents |
| | Executive Summary 1 |
| | Chapter 1 Introduction 12 |
| | The Life Sciences Today. 13 |
| | The “Dual use” Dilemma . 14 |
| | A Brief History of Biological Warfare . 15 |
| | U.S. Policy and the Creation of the Biological and Toxin Weapons Convention 17 |
| | The New Threat 17 |
| | Recent Examples of “Contentious Research” in the Life Sciences. 19 |
| | The Response of the Life Sciences Community to Previous Challenges . 23 |
| | Committee Charge and Process. 24 |
| | Annex: Biological Warfare in History. 27 |
| | Chapter 2 The Evolving Regulatory Environment for Life Sciences Research in the 21st Century 32 |
| | |
| | Introduction . 32 |
| | The U.S. Regulatory Environment 35 |
| | Framework for Implementation of the NIH Guidelines for rDNA Research. 36 |
| | Types of Experiments That Require IBC, RAC and NIH Director Review 38 |
| | Physical and Biological Containment Strategies for NIH-funded rDNA Research Activities. 38 |
| | Compliance with and Enforcement of the NIH Guidelines 39 |
| | Regulation of Microbial Agents (Listed Agents and Toxins) 40 |
| | Possession of Select Agents. 41 |
| | Importation and Interstate Shipment of Etiologic Agents 42 |
| | Oversight of Foreign Nationals 42 |
| | Professional Education and Responsibilities of Life Scientists . 44 |
| | The International Situation 45 |
| | Conclusions 48 |
| | Annex. 59 |
| | Chapter 3 Information Restriction and Control Regimes 62 |
| | Introduction . 62 |
| | Past as Prologue?. 63 |
| | Secret and Sensitive Information 67 |
| | Publication of Sensitive Information in the Life Sciences 71 |
| | Conclusions 72 |
| | Chapter 4 Conclusions and Recommendations 84 |
| | Introduction . 84 |
| | Key Assumptions 85 |
| | Recommendations 86 |
| | Conclusion 99 |
| | Appendix A 102 |
| | Appendix B 107 |